Amicus Therapeutics, Inc. (FOLD)
USD 6.51
(-5.52%)
USD 6.51
(-5.52%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 387.85 Million USD | -12.56% |
| 2022 | 443.56 Million USD | 2.51% |
| 2021 | 432.72 Million USD | -0.49% |
| 2020 | 434.85 Million USD | 114.18% |
| 2019 | 203.03 Million USD | -36.89% |
| 2018 | 321.74 Million USD | 95.98% |
| 2017 | 164.16 Million USD | 6.28% |
| 2016 | 154.46 Million USD | 271.3% |
| 2015 | 41.6 Million USD | 295.82% |
| 2014 | 10.51 Million USD | -25.85% |
| 2013 | 14.17 Million USD | 4640.47% |
| 2012 | 299 Thousand USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 1.04 Million USD | -55.46% |
| 2009 | 2.34 Million USD | 639.43% |
| 2008 | 317 Thousand USD | -73.45% |
| 2007 | 1.19 Million USD | -47.08% |
| 2006 | 2.25 Million USD | 207.21% |
| 2005 | 734.37 Thousand USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 388.93 Million USD | 0.14% |
| 2024 Q1 | 388.39 Million USD | 0.14% |
| 2023 Q4 | 387.85 Million USD | -13.14% |
| 2023 Q2 | 444.32 Million USD | 0.07% |
| 2023 Q1 | 444 Million USD | 0.1% |
| 2023 FY | 387.85 Million USD | -12.56% |
| 2023 Q3 | 446.52 Million USD | 0.49% |
| 2022 Q1 | 440.45 Million USD | 1.79% |
| 2022 Q2 | 443.49 Million USD | 0.69% |
| 2022 Q3 | 443.33 Million USD | -0.04% |
| 2022 Q4 | 443.56 Million USD | 0.05% |
| 2022 FY | 443.56 Million USD | 2.51% |
| 2021 FY | 432.72 Million USD | -0.49% |
| 2021 Q2 | 434.63 Million USD | 0.1% |
| 2021 Q3 | 432.21 Million USD | -0.56% |
| 2021 Q1 | 434.22 Million USD | -0.15% |
| 2021 Q4 | 432.72 Million USD | 0.12% |
| 2020 Q3 | 433.21 Million USD | 123.65% |
| 2020 Q1 | 202.25 Million USD | -0.38% |
| 2020 Q2 | 193.7 Million USD | -4.23% |
| 2020 FY | 434.85 Million USD | 114.18% |
| 2020 Q4 | 434.85 Million USD | 0.38% |
| 2019 Q4 | 203.03 Million USD | 2.06% |
| 2019 FY | 203.03 Million USD | -36.89% |
| 2019 Q1 | 204.91 Million USD | -36.31% |
| 2019 Q2 | 185.32 Million USD | -9.56% |
| 2019 Q3 | 198.94 Million USD | 7.35% |
| 2018 Q1 | 166.76 Million USD | 1.58% |
| 2018 Q3 | 318.8 Million USD | 88.15% |
| 2018 Q4 | 321.74 Million USD | 0.92% |
| 2018 FY | 321.74 Million USD | 95.98% |
| 2018 Q2 | 169.44 Million USD | 1.6% |
| 2017 Q2 | 159.17 Million USD | 1.47% |
| 2017 FY | 164.16 Million USD | 6.28% |
| 2017 Q4 | 164.16 Million USD | 1.57% |
| 2017 Q3 | 161.63 Million USD | 1.55% |
| 2017 Q1 | 156.85 Million USD | 1.55% |
| 2016 Q1 | 38.5 Million USD | -7.43% |
| 2016 FY | 154.46 Million USD | 271.3% |
| 2016 Q4 | 154.46 Million USD | 133.95% |
| 2016 Q3 | 66.02 Million USD | 1.12% |
| 2016 Q2 | 65.29 Million USD | 69.56% |
| 2015 Q3 | 50 Million USD | 0.0% |
| 2015 FY | 41.6 Million USD | 295.82% |
| 2015 Q1 | 9.2 Million USD | -12.39% |
| 2015 Q2 | - USD | -100.0% |
| 2015 Q4 | 41.6 Million USD | -16.8% |
| 2014 Q1 | 14.21 Million USD | 0.3% |
| 2014 FY | 10.51 Million USD | -25.85% |
| 2014 Q2 | 13.1 Million USD | -7.82% |
| 2014 Q3 | 11.8 Million USD | -9.88% |
| 2014 Q4 | 10.51 Million USD | -11.0% |
| 2013 Q4 | 14.17 Million USD | 0.0% |
| 2013 Q2 | 100 Thousand USD | -49.75% |
| 2013 Q1 | 199 Thousand USD | -33.44% |
| 2013 FY | 14.17 Million USD | 4640.47% |
| 2013 Q3 | - USD | -100.0% |
| 2012 Q4 | 299 Thousand USD | -24.87% |
| 2012 Q3 | 398 Thousand USD | -20.08% |
| 2012 Q1 | 597 Thousand USD | 0.0% |
| 2012 FY | 299 Thousand USD | 0.0% |
| 2012 Q2 | 498 Thousand USD | -16.58% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q1 | 731 Thousand USD | -29.98% |
| 2011 FY | - USD | -100.0% |
| 2011 Q3 | 104 Thousand USD | -75.12% |
| 2011 Q2 | 418 Thousand USD | -42.82% |
| 2010 Q3 | 1.35 Million USD | -18.74% |
| 2010 FY | 1.04 Million USD | -55.46% |
| 2010 Q4 | 1.04 Million USD | -23.07% |
| 2010 Q2 | 1.67 Million USD | -16.79% |
| 2010 Q1 | 2 Million USD | -14.38% |
| 2009 Q3 | 2.69 Million USD | 25.34% |
| 2009 Q2 | 2.15 Million USD | 864.57% |
| 2009 Q4 | 2.34 Million USD | -13.06% |
| 2009 FY | 2.34 Million USD | 639.43% |
| 2009 Q1 | 223 Thousand USD | -29.65% |
| 2008 Q3 | 483 Thousand USD | -30.5% |
| 2008 Q1 | 918 Thousand USD | -23.12% |
| 2008 FY | 317 Thousand USD | -73.45% |
| 2008 Q4 | 317 Thousand USD | -34.37% |
| 2008 Q2 | 695 Thousand USD | -24.29% |
| 2007 Q3 | 1.57 Million USD | -19.46% |
| 2007 Q1 | 1.9 Million USD | -15.47% |
| 2007 Q2 | 1.95 Million USD | 2.41% |
| 2007 Q4 | 1.19 Million USD | -24.09% |
| 2007 FY | 1.19 Million USD | -47.08% |
| 2006 Q4 | 2.25 Million USD | 0.0% |
| 2006 FY | 2.25 Million USD | 207.21% |
| 2005 Q4 | 734.37 Thousand USD | 0.0% |
| 2005 FY | 734.37 Thousand USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Keros Therapeutics, Inc. | 13.43 Million USD | -2786.063% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 83.446% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -6639.496% |
| AlloVir, Inc. | 16.64 Million USD | -2229.757% |
| Precigen, Inc. | 5.89 Million USD | -6479.44% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -6142.685% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -1012822.097% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -32060.697% |
| Acelyrin, Inc. | 1.19 Million USD | -32383.92% |
| AbCellera Biologics Inc. | 71.22 Million USD | -444.576% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -271.732% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Agenus Inc. | 137.32 Million USD | -182.44% |
| Dyadic International, Inc. | 88.87 Thousand USD | -436332.992% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -1762890.909% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -630604.436% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 1.83 Million USD | -20990.701% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -1022.404% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -3365.803% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -46461.585% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -444.775% |
| Alkermes plc | 287.73 Million USD | -34.799% |
| Aptorum Group Limited | 3.05 Million USD | -12581.314% |
| Ardelyx, Inc. | 51.54 Million USD | -652.436% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -270.773% |
| Bicycle Therapeutics plc | 40.08 Million USD | -867.71% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -285.552% |
| Chimerix, Inc. | 125 Thousand USD | -310186.4% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -11875.986% |
| CRISPR Therapeutics AG | 223 Million USD | -73.922% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1186.983% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| Fortress Biotech, Inc. | 60.85 Million USD | -537.337% |
| Fortress Biotech, Inc. | 60.85 Million USD | -537.337% |
| NextCure, Inc. | 5.94 Million USD | -6419.718% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 118.85 Thousand USD | -326223.229% |
| Opthea Limited | 200.53 Million USD | -93.411% |
| PDS Biotechnology Corporation | 19.5 Million USD | -1888.385% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -10104.104% |
| ImmuCell Corporation | 10.54 Million USD | -3579.694% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -34376.267% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -430260.392% |
| Incyte Corporation | 29.16 Million USD | -1230.012% |
| Jaguar Health, Inc. | 30.99 Million USD | -1151.437% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -1584.508% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| ContextLogic Inc. | 6 Million USD | -6364.3% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -235.866% |
| MiMedx Group, Inc. | 48.09 Million USD | -706.374% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -1829.738% |
| Seer, Inc. | 25.96 Million USD | -1393.83% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 168.01 Million USD | -130.846% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -823.735% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -267388.276% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -391675.758% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -1426.76% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -103.139% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -1654.14% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -489.835% |
| Pharming Group N.V. | 166.1 Million USD | -133.502% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -180.439% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| PureTech Health plc | 18.25 Million USD | -2025.249% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -636.56% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -1057.267% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -84216.957% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -10190.74% |
| Senti Biosciences, Inc. | 33.53 Million USD | -1056.473% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -8026.084% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -542.99% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -804.646% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -24604.331% |
| Windtree Therapeutics, Inc. | 15 Million USD | -2485.72% |
| ChromaDex Corporation | 2.57 Million USD | -14962.447% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -52886.066% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -1397.059% |
| Precision BioSciences, Inc. | 7.72 Million USD | -4922.116% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -298.375% |
| Innoviva, Inc. | 446.23 Million USD | 13.082% |
| Summit Therapeutics Inc. | 103.29 Million USD | -275.504% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -580143.552% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -87.4% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -12066.186% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -37265.896% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -1637.248% |
| Aptose Biosciences Inc. | 621 Thousand USD | -62357.005% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -38266.303% |
| Century Therapeutics, Inc. | 46.65 Million USD | -731.279% |
| Kura Oncology, Inc. | 9.33 Million USD | -4056.215% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -1352.652% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -280956.522% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -4032.744% |
| Autolus Therapeutics plc | 47.91 Million USD | -709.488% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -7805.789% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -5626.532% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -196.845% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -4685.416% |
| IGM Biosciences, Inc. | 34.67 Million USD | -1018.649% |
| INmune Bio, Inc. | 397 Thousand USD | -97597.229% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -123.224% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -9466.678% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -263840.551% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -679.269% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -610.753% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -748.835% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 18.064% |
| Verastem, Inc. | 40.08 Million USD | -867.565% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -8710.95% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -3757.748% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -5811.568% |
| Histogen Inc. | 4.38 Million USD | -8747.126% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -43874.83% |
| Organovo Holdings, Inc. | 888 Thousand USD | -43577.703% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -1192.86% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -9147.926% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -1952.702% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -412.362% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -416485.754% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -1397.117% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -145165.169% |
| Amarin Corporation plc | 8.73 Million USD | -4339.258% |
| Mesoblast Limited | 100.48 Million USD | -285.994% |
| Turnstone Biologics Corp. | 1.18 Million USD | -32520.521% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -395.165% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -355733.028% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -372.946% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -104.196% |
| Better Therapeutics, Inc. | 10.34 Million USD | -3648.145% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -1577.224% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -316.904% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -29919.969% |
| Gritstone bio, Inc. | 40.14 Million USD | -866.167% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -21281.367% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -152.523% |
| Insmed Incorporated | 1.19 Billion USD | 67.498% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -6008.0% |
| OmniAb, Inc. | 22.07 Million USD | -1657.001% |
| Alector, Inc. | 30.45 Million USD | -1173.503% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -281.961% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -4719.908% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 9.081% |
| Aura Biosciences, Inc. | 16.87 Million USD | -2199.099% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -581.72% |
| Immunic, Inc. | 639 Thousand USD | -60597.653% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -1200.708% |
| Veracyte, Inc. | 7.52 Million USD | -5054.259% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 39.854% |
| FibroGen, Inc. | 89.69 Million USD | -332.409% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -8843.002% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -296284.769% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 92.407% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1048164.865% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -19488.788% |
| TG Therapeutics, Inc. | 100.11 Million USD | -287.401% |
| Galecto, Inc. | 66 Thousand USD | -587563.636% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -285089.706% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 76.24% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -6348.18% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -7086.548% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -21281.367% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -1708.449% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -961.026% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -74920.89% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -757.41% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -1168.588% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -765.716% |
| Vaxxinity, Inc. | 13.26 Million USD | -2824.582% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 52.191% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -86272.433% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -4312.994% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 85.65% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -122639.873% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -8600.269% |
| Ainos, Inc. | 5.92 Million USD | -6449.934% |
| Pluri Inc. | 29.05 Million USD | -1235.002% |
| Prothena Corporation plc | 10.72 Million USD | -3517.741% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -1853.846% |
| Celularity Inc. | 26.17 Million USD | -1381.675% |
| Rallybio Corporation | 173 Thousand USD | -224095.376% |
| Cue Biopharma, Inc. | 4.2 Million USD | -9130.319% |
| MeiraGTx Holdings plc | 72.11 Million USD | -437.803% |
| Omeros Corporation | 329.7 Million USD | -17.638% |
| Humacyte, Inc. | 38.6 Million USD | -904.813% |
| Immunocore Holdings plc | 82.64 Million USD | -369.312% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -23945.753% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -10743.109% |
| Blueprint Medicines Corporation | 610.96 Million USD | 36.517% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -26502.058% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -307.461% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -696.685% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -326.682% |
| Pulmatrix, Inc. | 8.32 Million USD | -4557.836% |
| Elicio Therapeutics, Inc. | 6 Million USD | -6356.767% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -2896.199% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -300.899% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -82598.934% |
| Cytokinetics, Incorporated | 607.37 Million USD | 36.142% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -4362.241% |
| Nutriband Inc. | 79.82 Thousand USD | -485779.287% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -8549.822% |
| Vor Biopharma Inc. | 31.83 Million USD | -1118.53% |
| Roivant Sciences Ltd. | 477.85 Million USD | 18.834% |
| Evogene Ltd. | 10.65 Million USD | -3540.834% |
| ProKidney Corp. | 3.61 Million USD | -10643.989% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -51001.186% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -1473188.764% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 77.654% |
| CorMedix Inc. | 517.01 Thousand USD | -74919.003% |
| BioLineRx Ltd. | 6.62 Million USD | -5751.811% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -952.875% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -440.636% |
| Atai Life Sciences N.V. | 15.21 Million USD | -2449.852% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -45942.624% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -152001.176% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -798.86% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -94347.475% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -28231.483% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -58391.718% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -117.812% |
| Biomea Fusion, Inc. | 7.83 Million USD | -4853.487% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -36.467% |
| Mereo BioPharma Group plc | 5.3 Million USD | -7218.075% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -17939.907% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -65862.245% |
| Absci Corporation | 4.66 Million USD | -8223.133% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -3266.239% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -1609.002% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -3776.642% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -3271.213% |
| Allakos Inc. | 38.21 Million USD | -914.937% |
| Imunon, Inc. | 1.13 Million USD | -33943.745% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -4394.82% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -46294.498% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -3878480.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -339.022% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -8136.526% |
| XOMA Corporation | 118.51 Million USD | -227.257% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -3752.001% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -946.031% |
| aTyr Pharma, Inc. | 13.76 Million USD | -2717.302% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -4810.216% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -1453.669% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -1819.614% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -2585620.0% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -139321.978% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -2583.236% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 74.13% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -284727.389% |
| UroGen Pharma Ltd. | 98.55 Million USD | -293.561% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -160.108% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -1934.185% |
| Entera Bio Ltd. | 256 Thousand USD | -151407.031% |
| GH Research PLC | 631 Thousand USD | -61367.195% |
| Lisata Therapeutics, Inc. | 137.00 USD | -283107929.197% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -60314.019% |
| Xencor, Inc. | 14.64 Million USD | -2548.941% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -258040.046% |
| Replimune Group, Inc. | 71.99 Million USD | -438.766% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -258472.0% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -5436.083% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -284727.389% |
| Portage Biotech Inc. | 7000.00 USD | -5540728.571% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -58391.718% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -27041.917% |
| OncoCyte Corporation | 2.2 Million USD | -17497.913% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -579614.521% |
| Purple Biotech Ltd. | 163 Thousand USD | -237849.693% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -15200.118% |
| scPharmaceuticals Inc. | 38.81 Million USD | -899.351% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -1436.436% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -531212.329% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -20831.355% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -1372.059% |
| Curis, Inc. | 1.48 Million USD | -25948.22% |
| Daré Bioscience, Inc. | 3.91 Million USD | -9810.325% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -55489.747% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -6464200.0% |
| BeiGene, Ltd. | 197.61 Million USD | -96.267% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -42451.618% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -381.363% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -647.476% |
| bluebird bio, Inc. | 224.41 Million USD | -72.828% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 34.604% |
| DBV Technologies S.A. | 4.52 Million USD | -8469.554% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -28844.627% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -3881.297% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -10196.204% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -2.808% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -804.583% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -22489.284% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -41695.043% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -2120.519% |
| MacroGenics, Inc. | 30.19 Million USD | -1184.468% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -2090.917% |
| Prime Medicine, Inc. | 4.35 Million USD | -8801.951% |
| Aditxt, Inc. | 1.04 Million USD | -37131.604% |
| Adagene Inc. | 13.54 Million USD | -2764.528% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -2723.455% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 25.226% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -2169.104% |
| SciSparc Ltd. | 24 Thousand USD | -1615975.0% |
| Vericel Corporation | 81.85 Million USD | -373.83% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -372.901% |
| Generation Bio Co. | 89.77 Million USD | -332.038% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -1648.289% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -92.2% |
| Invivyd, Inc. | 722 Thousand USD | -53619.945% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -699.674% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -13265762.443% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -10040.078% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -1686239.13% |
| 2seventy bio, Inc. | 244.01 Million USD | -58.95% |
| ADMA Biologics, Inc. | 130.59 Million USD | -196.995% |
| Clene Inc. | 7.15 Million USD | -5323.07% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -11387.804% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -56.636% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -35127.793% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -147450.263% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -101.359% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -1265.553% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -3923.841% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -247.316% |
| Evaxion Biotech A/S | 8.48 Million USD | -4469.083% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -417.662% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -499.332% |
| Trevena, Inc. | 35.23 Million USD | -1000.837% |
| Surrozen, Inc. | 882 Thousand USD | -43874.83% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -6139.672% |
| Cingulate Inc. | 135.09 Thousand USD | -286991.688% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -1547.725% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -711.418% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -215376.667% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -1428.264% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -2124.339% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -41337.821% |
| Statera Biopharma, Inc. | 11.43 Million USD | -3292.995% |
| ImmunityBio, Inc. | 836.95 Million USD | 53.658% |
| Korro Bio, Inc. | 31.21 Million USD | -1142.497% |
| Kineta, Inc. | 150 Thousand USD | -258472.0% |
| BioVie Inc. | 349.89 Thousand USD | -110750.143% |
| Codexis, Inc. | 12.24 Million USD | -3067.998% |
| Celularity Inc. | 26.17 Million USD | -1381.675% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -715.599% |
| Celcuity Inc. | 37.03 Million USD | -947.263% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -219842.726% |
| Cibus, Inc. | 17.67 Million USD | -2094.512% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -11378.485% |
| Kodiak Sciences Inc. | 100 Million USD | -287.858% |
| Annexon, Inc. | 29.19 Million USD | -1228.736% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -500.149% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -34468.449% |
| Avalo Therapeutics, Inc. | 2 Million USD | -19292.9% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 72.303% |
| Eyenovia, Inc. | 8.95 Million USD | -4230.11% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -490.716% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -4663.67% |
| Arcellx, Inc. | 50.84 Million USD | -662.884% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -26502.058% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -1726.245% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -36663.791% |
| Moolec Science SA | 99.04 Thousand USD | -391493.805% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -1304.214% |
| Geron Corporation | 35.05 Million USD | -1006.553% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -65527.411% |
| Royalty Pharma plc | 6.13 Billion USD | 93.678% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -23521.072% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -1221807.882% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -1575.557% |
| Humacyte, Inc. | 38.6 Million USD | -904.813% |
| Structure Therapeutics Inc. | 4.01 Million USD | -9565.039% |
| 89bio, Inc. | 24.79 Million USD | -1464.259% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -3019.334% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -20685.531% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -37483.14% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -289.776% |
| Notable Labs, Ltd. | 1.52 Million USD | -25316.645% |
| Liquidia Corporation | 2.36 Million USD | -16306.853% |
| Mustang Bio, Inc. | 1.97 Million USD | -19508.595% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -2723.455% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -5478.283% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -122252.681% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -677.629% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -3938.505% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -592149.08% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -285089.706% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -6091.858% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -298252.308% |
| PepGen Inc. | 17.1 Million USD | -2168.175% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -81726.582% |
| United Therapeutics Corporation | 300 Million USD | -29.286% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -1520.058% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -9217.122% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -67003.46% |
| XOMA Corporation | 118.51 Million USD | -227.257% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -1048164.865% |
| Bionomics Limited | 117.62 Million USD | -229.733% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -41471.061% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -6813.69% |
| uniQure N.V. | 130.06 Million USD | -198.203% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -561.987% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -56439.067% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -8843.002% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -27904.188% |
| Altimmune, Inc. | 175 Thousand USD | -221533.143% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -6813.69% |
| Compugen Ltd. | 719 Thousand USD | -53844.089% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -7556.099% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -358.705% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -3805.921% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -5980.232% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -324.306% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -3805.921% |
| Instil Bio, Inc. | 81.42 Million USD | -376.326% |
| argenx SE | 15.35 Million USD | -2426.104% |
| Immunome, Inc. | 1.34 Million USD | -28844.627% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -72261.567% |
| Verona Pharma plc | 48.37 Million USD | -701.79% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -4108.529% |
| Shattuck Labs, Inc. | 3.4 Million USD | -11287.493% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -456203.529% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -230767.857% |
| Moolec Science SA | 99.04 Thousand USD | -391493.805% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -3415.733% |
| AnaptysBio, Inc. | 16.03 Million USD | -2318.52% |
| Design Therapeutics, Inc. | 2.33 Million USD | -16517.738% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -1432643.526% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -6364.3% |
| Achilles Therapeutics plc | 1.07 Million USD | -35946.283% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -4108.529% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -1945415.65% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -2216.617% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -485779.287% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -5198372.055% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -2983423.077% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -13.249% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -1484.128% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -15414.382% |
| Palisade Bio, Inc. | 90 Thousand USD | -430853.333% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -199826.804% |
| Beam Therapeutics Inc. | 159.91 Million USD | -142.546% |
| Neurogene Inc. | 13.37 Million USD | -2800.307% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -26.577% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -1376.823% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -648253.449% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -38685.8% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -857.485% |
| Athira Pharma, Inc. | 1.21 Million USD | -31770.008% |
| Vaccinex, Inc. | 26 Thousand USD | -1491661.538% |
| HCW Biologics Inc. | 6.3 Million USD | -6052.259% |
| XOMA Corporation | 118.51 Million USD | -227.257% |
| Nektar Therapeutics | 112.62 Million USD | -244.38% |
| Arvinas, Inc. | 800 Thousand USD | -48382.25% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -2583.236% |
| Merus N.V. | 10.48 Million USD | -3598.112% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -2505.697% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -2788.212% |
| Rezolute, Inc. | 1.66 Million USD | -23264.94% |
| Clene Inc. | 7.15 Million USD | -5323.07% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -528691.514% |
| BeyondSpring Inc. | 3.36 Million USD | -11429.667% |
| Synlogic, Inc. | 12.49 Million USD | -3005.1% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -1087.708% |
| Krystal Biotech, Inc. | 6.62 Million USD | -5758.882% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -126.925% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -6368.612% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -818666.756% |
| MannKind Corporation | 252.15 Million USD | -53.82% |
| Ikena Oncology, Inc. | 7.18 Million USD | -5301.922% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -194803.518% |
| Gossamer Bio, Inc. | 197.4 Million USD | -96.478% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -74488.077% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -37.867% |
| Mural Oncology plc | 8.91 Million USD | -4252.575% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -786.816% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -26909.61% |
| Champions Oncology, Inc. | 6.09 Million USD | -6265.633% |
| REGENXBIO Inc. | 82.22 Million USD | -371.72% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -78413.288% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -8647.361% |
| Vaxart, Inc. | 2.62 Million USD | -14686.809% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -142688.562% |
| Cellectis S.A. | 36.24 Million USD | -970.219% |
| Longeveron Inc. | 1.44 Million USD | -26685.773% |
| Repare Therapeutics Inc. | 1.01 Million USD | -38301.782% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 65.753% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -766.354% |
| Revolution Medicines, Inc. | 80.57 Million USD | -381.363% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -11990.337% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -219028.814% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -315231.707% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 46.48% |
| Denali Therapeutics Inc. | 44.98 Million USD | -762.271% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -3001.809% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -286991.688% |
| Passage Bio, Inc. | 22.92 Million USD | -1592.151% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -6322.553% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -59847.141% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -1823.422% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -79054.694% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -95089.922% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -32547.98% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -83131.33% |
| OmniAb, Inc. | 22.07 Million USD | -1657.001% |
| Anew Medical, Inc. | 1.54 Million USD | -25085.584% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -1212.105% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -4193.789% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -1147.533% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -9466.678% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -652.29% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -5991.692% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2645.12% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -57616.964% |
| Alumis Inc. Common Stock | 30.86 Million USD | -1156.831% |
| Equillium, Inc. | 384 Thousand USD | -100904.688% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -6197.418% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -156.776% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -693.506% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -322303.618% |
| Dominari Holdings Inc. | 3.02 Million USD | -12709.049% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -1961453.634% |
| vTv Therapeutics Inc. | 169 Thousand USD | -229401.775% |
| Bio-Techne Corporation | 319 Million USD | -21.586% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -580.596% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -117.207% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -2417.414% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -3032.181% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -7968.608% |
| Nkarta, Inc. | 82.27 Million USD | -371.445% |
| BioCardia, Inc. | 982 Thousand USD | -39396.741% |
| Iterum Therapeutics plc | 18.95 Million USD | -1946.096% |